Rentokil shares fall after third warning on North America weakness
Shares have lost about a third in value since October 2023
Company to cut US jobs to address cost overruns
Says North America sales in July and August lower than expected
Adds CEO comment in paragraph 3, details on Terminix deal and analyst quote in paragraphs 10-12
By Yamini Kalia and Yadarisa Shabong
Sept 11 (Reuters) -Rentokil Initial RTO.L warned of lower annual profit on Wednesday after weaker than expected sales in its largest market North America, sending shares of the British pest control company as much as 20% down.
This is the third warning about weakness in its North America business in the past year.
In a conference call with analysts and investors, CEO Andy Ransom expressed disappointment in the execution of the group's strategy, launched in March, to improve revenue growth. He, however, added that he had confidence in the plan and would not change it.
The company's shares, which have lost about a third of their value since the first North America warning in October last year, were down 20% to 380 pence at 0800 GMT. The stock was the biggest loser on the FTSE 100 index .FTSE.
Rentokil, which made about 60% of its revenue in North America last year, said it would cut an undisclosed number of jobs in its U.S. workforce to address cost overruns.
Rentokil now expects full-year adjusted pretax profit to be about 700 million pounds ($916 million), versus the 766 million pounds it reported last year.
Analysts at RBC Capital Markets had expected pretax profit of about 777 million pounds.
North America sales in July and August came in lower than anticipated, organic revenue growth is now expected to grow about 1% in the second half.
The company had previously expected revenue growth to be at the lower end of a 2-4% growth range.
Rentokil, which bought U.S rival Terminixin 2021, has been struggling to integrate its business and said on Wednesday it saw a modest disruption to organic growth from the deal.
About 5.4 billion pounds have been wiped from the pest control company's market capitalisation since it issued its first profit warning in October 2023.
"The profit warning will raise further questions on management control and visibility in the region," Jefferies' analyst Allen Wells said in a note.
The company has also increased its spending on marketing in a bid to attract more customers in North America.
Activist investor Nelson Peltz's Trian Fund Management has built a stake in the company and in June said it was interested in discussing "ideas and initiatives".
Rentokil and rival Rollins account for roughly half of the U.S. pest control market, with Rentokil the larger player following the Terminix deal.
($1 = 0.7642 pounds)
Reporting by Shanima A, Yamini Kalia and Yadarisa Shabong in Bengaluru; Editing by Sherry Jacob-Phillips and Mark Potter
Mga Kaugnay na Asset
Pinakabagong Balita
Disclaimer: Ang mga kabilang sa XM Group ay nagbibigay lang ng serbisyo sa pagpapatupad at pag-access sa aming Online Trading Facility, kung saan pinapahintulutan nito ang pagtingin at/o paggamit sa nilalaman na makikita sa website o sa pamamagitan nito, at walang layuning palitan o palawigin ito, at hindi din ito papalitan o papalawigin. Ang naturang pag-access at paggamit ay palaging alinsunod sa: (i) Mga Tuntunin at Kundisyon; (ii) Mga Babala sa Risk; at (iii) Kabuuang Disclaimer. Kaya naman ang naturang nilalaman ay ituturing na pangkalahatang impormasyon lamang. Mangyaring isaalang-alang na ang mga nilalaman ng aming Online Trading Facility ay hindi paglikom, o alok, para magsagawa ng anumang transaksyon sa mga pinansyal na market. Ang pag-trade sa alinmang pinansyal na market ay nagtataglay ng mataas na lebel ng risk sa iyong kapital.
Lahat ng materyales na nakalathala sa aming Online Trading Facility ay nakalaan para sa layuning edukasyonal/pang-impormasyon lamang at hindi naglalaman – at hindi dapat ituring bilang naglalaman – ng payo at rekomendasyon na pangpinansyal, tungkol sa buwis sa pag-i-invest, o pang-trade, o tala ng aming presyo sa pag-trade, o alok para sa, o paglikom ng, transaksyon sa alinmang pinansyal na instrument o hindi ginustong pinansyal na promosyon.
Sa anumang nilalaman na galing sa ikatlong partido, pati na ang mga nilalaman na inihanda ng XM, ang mga naturang opinyon, balita, pananaliksik, pag-analisa, presyo, ibang impormasyon o link sa ibang mga site na makikita sa website na ito ay ibibigay tulad ng nandoon, bilang pangkalahatang komentaryo sa market at hindi ito nagtataglay ng payo sa pag-i-invest. Kung ang alinmang nilalaman nito ay itinuring bilang pananaliksik sa pag-i-invest, kailangan mong isaalang-alang at tanggapin na hindi ito inilaan at inihanda alinsunod sa mga legal na pangangailangan na idinisenyo para maisulong ang pagsasarili ng pananaliksik sa pag-i-invest, at dahil dito ituturing ito na komunikasyon sa marketing sa ilalim ng mga kaugnay na batas at regulasyon. Mangyaring siguruhin na nabasa at naintindihan mo ang aming Notipikasyon sa Hindi Independyenteng Pananaliksik sa Pag-i-invest at Babala sa Risk na may kinalaman sa impormasyong nakalagay sa itaas, na maa-access dito.
